期刊文献+

微量白蛋白尿及假性血友病因子与高血压代谢综合征的关系 被引量:2

Association of microalbuminuria and von Willebrand factor with metabolic syndrome in hypertensive patients
下载PDF
导出
摘要 目的:比较伴代谢综合征的高血压患者与单纯高血压患者的微量白蛋白尿(microalbuminuria,MAU)及假性血友病因子(von Willebrand factor,vWF)水平的差异,探讨二者与代谢综合征的关系。方法:连续收治的133例患者,根据2005年国际糖尿病联盟(International Diabetes Federation,IDF)代谢综合征全球定义分为伴代谢综合征(metabolic syndrome,MS)的高血压组(97例)与单纯高血压组(36例)。测定血生化、血浆vWF、24h尿白蛋白排泄率(urine albumin excretion,UAE)及晨尿白蛋白/肌苷比(albumin/creatinine ratio,ACR)。应用统计学方法分析MAU、vWF与代谢综合征的关系。结果:同单纯的高血压患者相比,伴MS的高血压患者腰围、体重指数、甘油三酯(triglyceride,TG)及低密度脂蛋白胆固醇(low density lipoprotein cholesterol,LDL-C)升高(P<0.05或<0.01),而高密度脂蛋白胆固醇(high density lipoprotein cholesterol,HDL-C)降低(P<0.01);血浆vWF含量及UAE增加(P均<0.05)。高血压患者UAE与ACR之间存在显著相关性(r=0.707,P<0.01)。而vWF与UAE及ACR则未见显著的相关性(r分别为0.079及0.052,P均>0.05)。Logistic回归分析显示HDL-C,TG,LDL-C,vWF及UAE与高血压患者MS的发生具有关联性(相应的标准化回归系数分别为-0.825,0.63,0.339,0.331,0.371,P<0.05或<0.01)。结论:相比单纯高血压,伴MS的高血压患者MAU增加,内皮损伤程度更重。UAE与ACR显著相关。vWF、UAE均与高血压患者MS的发生有关。 Objective: To compare the difference of microalbuminuria (MAU) and von Willebrand factor (vWF) between essential hypertensives and hypertensive patients with metabolic syndrome (MS), and to explore the association of these factors with MS. Methods: According to the new definition of MS by International Diabetes Federation (IDF) for 2005, 133 consecutive essential hypertensives were divided into two groups: hypertensive patients with metabolic syndrome (EH-MS group, n =97 ), and essential hypertensives (EH group, n = 36). Biochemistry assay, plasma vWF, 24 hours urine albumin excretion (UAE) and morning urine albumin/creatinine ratio (ACR) were measured. The association of MAU and vWF with MS was analysed. Results: Waist circumference, body mass index, triglyceride (TG), low density lipoprotein cholesterol ( LDL-C ) , plasma vWF and UAE were increased ( P 〈 0.05 or P 〈 0.01, respectively), while high density lipoprotein cholesterol (HDL-C) was decreased (P 〈 0.01 ) in EH-MS group, as compared with those in EH group. UAE was positively correlated with ACR (r = 0. 707, P 〈 0.01 ). vWF was not correlated with UAE or ACR (r = 0. 079 and 0. 052,P 〉 0.05, respectively). Logistic regression showed HDL-C, TG, LDL-C,vWF and UAE were associated with the development of MS in hypertensive patients (standardized coefficients: -0. 825, 0.63, 0. 339, 0. 331, 0. 371 ,P 〈0.05 or P 〈 0.01, respectively). Conclusion: Compared with essential hypertensives, the hypertensive patients with MS had more MAU and serious endothelial dysfunction. UAE was correlated significantly with ACR. vWF and UAE were associated with the development of MS in patients with hypertension.
出处 《北京大学学报(医学版)》 CAS CSCD 北大核心 2007年第6期587-590,共4页 Journal of Peking University:Health Sciences
关键词 高血压 代谢综合征X 白蛋白尿 von WILLEBRAND因子 Hypertension Metabolic syndrome X Albuminuria von Willebrand factor
  • 相关文献

参考文献11

  • 1Alberti KG, Zimmet P, Shaw J. The metabolic syndrome-a new worldwide definition [ J ]. Lancet. 2005, 366 : 1059 - 1062. 被引量:1
  • 2Weir MR. Microalbuminuria in type 2 diabetics: an important, over-looked cardiovascular risk factor[J]. J Clin Hypertens, 2004, 6:134- 141. 被引量:1
  • 3Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey[J]. Lancet, 1988,2:530-533. 被引量:1
  • 4Spencer CGC, Gumey D, Blann AD, et al. Von willebrand factor, soluble P-selectin, and target organ damage in hypertension: A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial[ J ]. Hypertension, 2002,40:61 - 66. 被引量:1
  • 5Palaniappan L, Carnethon M, Fortmann SP. Association between microalbuminuria and the metabolic syndrome: NHANES III[ J ]. Am J Hypertens, 2003, 16:952 -958. 被引量:1
  • 6Choi HS, Ryu SH, Lee KB. The relationship of microalbuminuria with metabolic syndrome [ J ]. Nephron Clinical Practice, 2006, 104 : c85 - c93. 被引量:1
  • 7辛岗,王芳,王梅,焦莉莉,徐国宾,王海燕.点时间尿蛋白与尿肌酐比值检测的临床应用评价[J].中华肾脏病杂志,2005,21(5):247-250. 被引量:45
  • 8Cottone S, Mule G, Nardi E, et al. Endothelial activation and insulin resistance: Comparison between essential hypertensives and hypertensive patients with metabolic syndrome [ J ]. Am J Hypertens,2005, 18 ( suppl 5 ) : 179. 被引量:1
  • 9Stehouwer CD, Nauta JJ, Zeldenrust GC, et al. Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus [ J ]. Lancet, 1992, 340 : 319 - 323. 被引量:1
  • 10Pedrinelli R, Giampietro O, Carmassi F, et al. Microalbuminuria and endothelial dysfunction in essential hypertension[ J]. Lancet, 1994,344 : 14 - 18. 被引量:1

二级参考文献21

  • 1[1]Dahlof B,Devereux RB,Kjeldsen SE,et al.Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in hypertension study (LIFE):a randomised trial against atenolol[J].Lancet,2002,359:995-1003. 被引量:1
  • 2[2]Lip GYH,Blann AD.Does hypertension confer a prothrombotic state?[J].Circulation,2000,101:218-220. 被引量:1
  • 3[3]Blann AD,McCollum CN,Lip GYH.Relationship between plasma markers of endothelial cell integrity and the Framingham cardiovascular disease risk-factor score in apparently healthy individuals[J].Blood Coagul Fibrinolysis,2003,14:315-317. 被引量:1
  • 4[4]Spencer CGC,Gurney D,Blann AD,et al.Von willebrand factor,soluble p-selectin,and target organ damage in hypertension:a substudy of the Anglo-Scandinavian cardiac outcomes trial[J].Hypertens,2002,40:61-66. 被引量:1
  • 5[5]Brown NJ.Blood pressure reduction and tissue-type plasminogen activator release[J].Hypertens,2006,47:648-649. 被引量:1
  • 6[6]Chandler WL,Alessi MC,Aillaud MF,et al.Clearance of tissue plasminogen activator(tPA) and TPA/plasmiongen activator inhibitor type 1 (PAI-1) complex relationship to elevated tPA antigen in patients with high PAI-1 activity levels[J].Circulation,1997,96:761-768. 被引量:1
  • 7[7]Brown NJ,Kumar S,Painter CA,et al.ACE inhibition versus angiotensin type 1 receptor antagonism:differential effects on PAI-1 over time[J].Hypertension,2002,40:859-865. 被引量:1
  • 8[8]Makris TK,Stavroulakis G,Papadopoulos DP,et al.Eprosartan effect on fibrinolytic/hemostatic variables in arterial hypertension:a comparative study to losartan[J].Drugs Exp Clin Res,2004,30:125-132. 被引量:1
  • 9[9]Lindholm LH,Carlberg B,Samuelsson O.Should β blockers remain first choice in the treatment of primary hypertension? A meta-analysis[J].Lancet,2005,366:1545-1553. 被引量:1
  • 10Neithardt AB, Dooley SL, Borensztajn J. Prediction of 24-hour protein excretion in pregnancy with a single voided urine protein-to-creatinine ratio. Am J Obstet Gynecol, 2002,186:883-886. 被引量:1

共引文献54

同被引文献3

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部